Investors

Investors

We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians.

News

Jun 01, 2021

Singular Genomics Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 26, 2021

Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

Presentations & Events

More events are coming soon.

Latest Earnings

Quarterly Earnings Results will become available soon.

Media Contacts

Dan Budwick

1AB

973-271-6085

Email Us
stock backfround image

Data provided by Refinitiv. Minimum 15 minutes delayed.